×

Search for jobs Submit your CV Register with us Login

Pharmaceutical Medical Devices Science Healthcare Communications Service Engineering Laboratory Staff Consumer Dental Animal Health

CV style and content Interview tips Job offer salary negotiation Resigning Developing your career Working from home Salary Surveys Work life balance Surveys

Pharmaceutical Medical Devices Science Healthcare Communications Service Engineering Laboratory Staff Consumer Dental Animal Health

Request call back Post a brief Salary Surveys Team Zenopa

Multi supplier Dedicated service Retained Executive Search

Contract Hourly paid Day, annual rates Interim

Pharmaceutical Medical Devices Science Healthcare Communications Service Engineering Laboratory Staff Consumer Dental Animal Health

Client ethos Market mapping About us Candidate engagement policy

Blog Industry news Testimonials Clients

Pharmaceutical Medical Devices Science Healthcare Communications Service Engineering Laboratory Staff Consumer Dental Animal Health

Request call back Post a brief Submit your CV Submit feedback

Phone 01494 818000

Pharmaceutical Medical Devices Science Healthcare Communications Service Engineering Laboratory Staff Consumer Dental Animal Health

Executive Support Services Graduate Roles

Jobs at Zenopa Office and location What we are about Being a great place to work Team Zenopa History of Zenopa About us

Register Login

TALENT DRIVEN ▲ CULTURE FOCUSED

Send us a message or CV

Roche

Roles

Clients

All clients

News from Zenopa

WHO Approves Roche’s Actemra/RoActemra Covid 19 Treatment

WHO Approves Roche’s Actemra/RoActemra Covid 19 Treatment

15 February 2022

Roche buys back over 53 million shares from Novartis

Roche buys back over 53 million shares from Novartis

8 December 2021

IMPACT trial tests benefit of Roche's new test for women at risk of cervical cancer

IMPACT trial tests benefit of Roche's new test for women at risk of cervical cancer

12 November 2021

Novartis sells a third of Roche for over $20bn

Novartis sells a third of Roche for over $20bn

8 November 2021

Roche has acquired TIB Molbiol

Roche has acquired TIB Molbiol

14 September 2021

Roche’s PDS with ranibizumab for nAMD accepted by FDA

Roche’s PDS with ranibizumab for nAMD accepted by FDA

FDA grants Roche’s Actemra/RoActemra EUA for hospitalised adults and paedriatrics with Covid-19

FDA grants Roche’s Actemra/RoActemra EUA for hospitalised adults and paedriatrics with Covid-19

Roche has reported positive results after its Phase III trial

Roche has reported positive results after its Phase III trial

More news

Blog

Meet the team

"We work with a few recruitment consultants and Mark is definitely one of the most proactive and professional."

"I would like to thank you for you expert and professional help in placing me with Pharmanovia, I found you and your staff very helpful through the whole process and wouldn’t have any problem in reco..."

"I have been greatly impressed with the service I have received from Zenopa, especially from Waheeda. From the very beginning she has been a pleasure to deal with."

Related Tags

glucose blood diabetes pharmacy

Sector

Pharmaceutical

Medical Devices

Science

Consumer

Dental

Animal Health

Healthcare Communications

PR

Service Engineering

Contact Us